Mazen Hanna
Presidente presso Transgenex Nanobiotech, Inc.
Posizioni attive di Mazen Hanna
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Transgenex Nanobiotech, Inc.
 Transgenex Nanobiotech, Inc. BiotechnologyHealth Technology Transgenex Nanobiotech, Inc. operates as a biotechnology company which engages in the discovery and development of nanoparticle formulations and nano-encapsulation methods for the treatment of acute and chronic lung diseases and cancers. It focuses on the development and marketing of diagnostic reagents/kits for the early detection of cancers and viral infections. The company was founded by Subhra Mohapatra and Shyam Mohaptra in 2004 and is headquartered in Lutz, FL. | Direttore/Membro del Consiglio | - | - |
| Presidente | - | - |
Storia della carriera di Mazen Hanna
Precedenti posizioni note di Mazen Hanna
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Thar Pharmaceuticals, Inc.
 Thar Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Thar Pharmaceuticals, Inc. operates as a specialty pharmaceutical company. The firm focuses on transforming intravenous drugs into oral drugs for existing and new indications. The company was founded by Mazen Hanna and Raymond K. Houck and is headquartered in Pittsburgh, PA. | Direttore Tecnico/Scientifico/R&S | - | 01/11/2016 |
| Fondatore | - | 01/11/2016 | |
| Thar Pharma Ltd. | Direttore/Membro del Consiglio | - | - |
| Direttore Tecnico/Scientifico/R&S | - | - | |
Nektar Therapeutics UK Ltd.
 Nektar Therapeutics UK Ltd. Pharmaceuticals: MajorHealth Technology Part of Nektar Therapeutics, Nektar Therapeutics UK Ltd. develops and manages the exploitation of patented technology for controlled particle formation. The company is based in Bradford, UK. Nektar Therapeutics was acquired by Nektar Therapeutics on January 09, 2001 for $140.98 million. The British company was founded by Mazen Hanna, Gwynfor Owen Humphreys. | Fondatore | - | - |
Formazione di Mazen Hanna
| University of Bradford | Doctorate Degree |
| University of Baghdad | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Regno Unito | 4 |
| Stati Uniti | 3 |
| Iraq | 2 |
Posizioni
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
| Director/Board Member | 2 |
Settori
| Health Technology | 4 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 4 |
|---|---|
Thar Pharmaceuticals, Inc.
Thar Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Thar Pharmaceuticals, Inc. operates as a specialty pharmaceutical company. The firm focuses on transforming intravenous drugs into oral drugs for existing and new indications. The company was founded by Mazen Hanna and Raymond K. Houck and is headquartered in Pittsburgh, PA. | Health Technology |
Nektar Therapeutics UK Ltd.
Nektar Therapeutics UK Ltd. Pharmaceuticals: MajorHealth Technology Part of Nektar Therapeutics, Nektar Therapeutics UK Ltd. develops and manages the exploitation of patented technology for controlled particle formation. The company is based in Bradford, UK. Nektar Therapeutics was acquired by Nektar Therapeutics on January 09, 2001 for $140.98 million. The British company was founded by Mazen Hanna, Gwynfor Owen Humphreys. | Health Technology |
| Thar Pharma Ltd. | |
Transgenex Nanobiotech, Inc.
Transgenex Nanobiotech, Inc. BiotechnologyHealth Technology Transgenex Nanobiotech, Inc. operates as a biotechnology company which engages in the discovery and development of nanoparticle formulations and nano-encapsulation methods for the treatment of acute and chronic lung diseases and cancers. It focuses on the development and marketing of diagnostic reagents/kits for the early detection of cancers and viral infections. The company was founded by Subhra Mohapatra and Shyam Mohaptra in 2004 and is headquartered in Lutz, FL. | Health Technology |
- Borsa valori
- Insiders
- Mazen Hanna
- Esperienza
